Helicobacter pylori infection and its role in human disease - An overview

Pharmacy World and Science

Volumn 18, Issue 2, 1996, Pages 49-55

  McColl, K E L ^a  

^a WESTERN INFIRMARY   (United Kingdom)

Author keywords

duodenal ulcer; eradication therapy; gastric cancer; Helicobacter pylori

Indexed keywords

AMOXICILLIN; ANTIBIOTIC AGENT; BACTERIAL VACCINE; BISMUTH CITRATE; CIMETIDINE; CLARITHROMYCIN; HISTAMINE H2 RECEPTOR ANTAGONIST; METRONIDAZOLE; OMEPRAZOLE; TETRACYCLINE;

BACTERIAL INFECTION; BACTERICIDAL ACTIVITY; DISEASE ASSOCIATION; DYSPEPSIA; GASTRODUODENAL ULCER; GASTROESOPHAGEAL REFLUX; HELICOBACTER PYLORI; HUMAN; PATHOPHYSIOLOGY; REVIEW; STOMACH CANCER;

DRUG THERAPY, COMBINATION; ENZYME TESTS; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; PEPTIC ULCER; STOMACH NEOPLASMS; UREASE;

EID: 0029884460     PISSN: 09281231     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF00579705     Document Type: Review

References (84)

1. Graham DY, Malaty HM, Evans DG, Evans D Jr, Klein PD, Adam E. Epidemiology of Helicobacter pylori in an asymptomatic population in the United States. Gastroenterology 1991;100:1495-1501.
2. Hook-Nikanne J, Sistonen P, Kosunen TU. Effect of ABO blood group and secretor status on the frequency of Helicobacter pylori antibodies. Scand J Gastroenterol 1990;25:815-8.
3. Veldhuyzen van Zanten SJO, Pollak PT, Best LM, Bezanson GS, Marrie T. Increasing prevalence of Helicobacter pylori infection with age: continuous risk of infection in adults rather than cohort effect. J Infect Dis 1994;169:434-7.
4. Kosunen TU, Hook J, Rautelin HI, Myllyla G. Age-dependent increase of Campylobacter pylori antibodies in blood donors. Scand J Gastroenterol 1989;24:110-4.
5. Cullen DJE, Collins BJ, Christiansen KJ, Epis J, Warren JR, Surveyor I, Cullen KJ. When is Helicobacter pylori infection acquired? Gut 1993;34:1681-2.
6. Mitchell HM, Li YY, Hu PJ, Liu Q, Chen M, Du GG, et al. Epidemiology of Helicobacter pylori in Southern China: identification of early childhood as the critical period for acquisition. J Infect Dis 1992;166:149-53.
7. Holcombe C. Helicobacter pylori: the African enigma. Gut 1992;33:429-31.
8. Sullivan PB, Thomas JE, Wight DGD, Neale G, Eastham EJ, Corrah T, et al. Helicobacter pylori in Gambian children with chronic diarrhoea and malnutrition. Arch Dis Child 1990;65:189-91.
9. Goodwin CS, Armstrong JA. Microbiological aspects of Helicobacter pylori (Campylobacter pylori). Eur J Clin Microbiol Infect Dis 1990;9:1:1-13.
10. Sjostedt S, Kager L, Veress B, Nord CE. Campylobacter pylori in relation to other aerobic and anaerobic microorganisms in patients with gastric diseases. Microb Ecol Health Dis 1989;2:107-14.
11. Bayerdorffer E, Lehn N, Hatz R, Mannes GA, Oertel H, Sauerbruch T, et al. Difference in expression of Helicobacter pylori gastritis in antrum and body. Gastroenterology 1992;102:1575-82.
12. Fiocca R, Villani L, Luinetti O, Gianatti A, Perego M, Alvisi C, et al. Helicobacter colonisation and histopathological profile of chronic gastritis in patients with or without dyspepsia, mucosal erosion and peptic ulcer: a morphological approach to the study of ulcerogenesis in man. Virchows Archiv A Pathol Anat 1992;420:489-98.
13. Rauws EA, Langenberg W, Houthoff HJ, Zanen HC, Tytgat GN. Campylobacter pyloridis-associated chronic active antral gastritis. A prospective study of its prevalence and the effects of antibacterial and antiulcer treatment. Gastroenterology 1988;94:33-40.
14. Johnston BJ, Reed PI, Ali MH. Campylobacter-like organisms in duodenal and antral endoscopic biopsies: relationship to inflammation. Gut 1986;27:1132-7.
15. Satoh K, Kimura K, Yoshida Y, Kasano T, Kihira K, Taniguchi Y. Relationship between Helicobacter pylori colonization and acute inflammation of the duodenal mucosa. Am J Gastroenterol 1993;88:3:360-3.
16. Howden CW, Hunt RH. Relationship between gastric secretion and infection. Gut 1987;28:96-107.
17. Mobley HLT, Cortesia MJ, Rosenthal LE, Jones BD. Characterization of urease from Campylobacter pylori. J Clin Microbiol 1988;26:5:831-6.
18. Neithercut WD, Milne A, Chittajallu RS, Nujumi AM El, McColl KEL. Detection of Helicobacter pylori infection of the gastric mucosa by measurement of gastric aspirate ammonium and urea concentrations. Gut 1991;32:973-6.
19. Marshall BJ, Barrett LJ, Prakash C, McCallum RW, Guerrant RL. Urea protects Helicobacter (Campylobacter) pylori from the bactericidal effect of acid. Gastroenterology 1990;99:697-702.
20. Warren JR, Marshall B. Unidentified curved bacilli on gastric epithelium in active chronic gastritis. Lancet 1983;i:1273-5.
21. Marshall BJ, Warren R, Francis GJ, Langton SR, Goodwin CS, Blincow ED. Rapid urease test in the management of Campylobacter pyloridis-associated gastritis. Am J Gastroenterol 1987;82;3:200-10.
22. Schnell GA, Schubert TT. Usefulness of culture, histology and urease testing in the detection of Campylobacter pylori. Am J Gastroenterol 1989;84:2:133-99.
23. 13C-Urea breath test. Lancet 1987;ii:1174-7.
24. Marshall BJ, Surveyor I. Carbon-14 urea breath test for the diagnosis of Campylobacter pylori associated gastritis. J Nucl Med 1988;29:11-6.
25. 13carbon urea breath test for Helicobacter pylori: comparison with histology, culture, and ELISA serology. Gut 1991;32:1461-4.
26. Veenendaal RA, Pena AS, Mejjer JL, Endtz HPh, van der Est MMC, van Duijn W, et al. Long term serological surveillance after treatment of Helicobacter pylori infection. Gut 1991;32:1291-4.
27. Goossens H, Glupczynski Y, Burette A, van den Borre C, Butzler J-P. Evaluation of a commercially available second-generation immunoglobulin G enzyme immunoassay for detection of Helicobacter pylori infection. J Clin Microbiol 1992;176-80.
28. McColl KEL, El-Nujumi AM, Chittajallu RS, Dahill SW, Dorrian CA, El-Omar E, et al. A study of the pathogenesis of Helicobacter pylori negative chronic duodenal ulceration. Gut 1993;34:762-8.
29. Coghlan JG, Gilligan D, Humphries H, McKenna D, Dooley C, Sweeney E, et al. Campylobacter pylori and recurrence of duodenal ulcers - a 12 month follow-up study. Lancet 1987;ii:1109-11.
30. Hentschel E, Brandstatter G, Dragosics B, Hirschl AM, Nemec H, Schutze K, et al. Effect of ranitidine and amoxycillin plus metronidazole on the eradication of Helicobacter pylori and the recurrence of duodenal ulcer. N Engl J Med 1993;328:308-12.
31. O'Riordan T, Mathai E, Tobin E, McKenna D, Keane C, Sweeney E, et al. Adjuvant antibiotic therapy in duodenal ulcers treated with colloidal bismuth subcitrate. Gut 1990;31:999-1002.
32. Tatsuta M, Ishikawa H, Iishi H, Okuda S, Yokota Y. Reduction of gastric ulcer recurrence after suppression of Helicobacter pylori by cefixime. Gut 1990;31:973-6.
33. Graham DY, Lew GM, Klein PD, Evans DG, Evans DJ, Saeed ZA, et al. Effect of treatment of Helicobacter pylori infection on the long-term recurrence of gastric or duodenal ulcer. Ann Intern Med 1992;116:9:705-8.
34. Rune SJ, Hansen JM, Jensen TG, Eriksen J, Thomsen OO, Scheibel J, et al. Prevention of duodenal ulcer recurrence with penicillin. A double-blind, placebo-controlled trial. Scand J Gastroenterol 1993;28:438-42.
35. Mantzaris G J, Hatzis A, Tamvakologos G, Petraki K, Spiliades C, Triadaphyllou G. Prospective, randomized, investigator-blind trial of Helicobacter pylori infection treatment in patients with refractory duodenal ulcers. Dig Dis Sci 1993;38:6:1132-6.
36. Schutze K, Hentschel E, Brandstatter G. More on the eradication of Helicobacter pylori and the recurrence of duodenal ulcer. N Engl J Med 1993;328:1356.
37. Hosking SW, Ling TK, Chung SCS, Yung MY, Cheng AFB, Sung JJY, et al. Duodenal ulcer healing by eradication of Helicobacter pylori without anti-acid treatment: randomised controlled trial. Lancet 1994;343;508-10.
38. Forbes GM, Glaser ME, Cullen DJ, Warren JR, Christiansen KJ, Marshall BJ, et al. Duodenal ulcer treated with Helicobacter pylori eradication: seven-year follow up. Lancet 1994;343:258-60.
39. Marshall BJ, Goodwin CS, Warren JR, Murray R, Blincow ED, Blackbourn SJ, et al. Prospective double-blind trial of duodenal ulcer relapse after eradication of Campylobacter pylori. Lancet 1988;ii:1437-41.
40. Rauws EAJ, Tytgat GNJ. Cure of duodenal ulcer associated with eradication of Helicobacter pylori. Lancet 1990;335:1233-5.
41. Wilhelmsen I, Berstad A. Quality of life and relapse of duodenal ulcer before and after eradication of Helicobacter pylori. Scand J Gastroenterol 1994;29:874-9.
42. Graham DY, Hepps KS, Ramirez FC, Lew GM, Saeed ZA. Treatment of Helicobacter pylori reduces the rate of rebleeding in peptic ulcer disease. Scand J Gastroenterol 1993;28:939-42.
43. Labenz J. Role of Helicobacter pylori eradication in the prevention of peptic ulcer bleeding relapse. Digestion 1994;55:19-23.
44. McColl KEL, Fullarton GM, Chittajallu R, El-Nujumi AM, Macdonald AMI, Dahill SW, et al. Plasma gastrin, daytime intragastric pH, and nocturnal acid output before and at 1 and 7 months after eradication of Helicobacter pylori in duodenal ulcer subjects. Scand J Gastroenterol 1991;26:339-46.
45. Graham DY, Opekum A, Lew GM, Evans DJ, Klein PD, Evans DG. Ablation of exaggerated meal-stimulated gastrin release in duodenal ulcer patients after clearance of Helicobacter (Campylobacter) pylori infection. Am J Gastroenterol 1990;85:394-8.
46. Levi S, Beardshall K, Haddad G, Playford R, Ghosh P, Calam J. Campylobacter pylori and duodenal ulcers: the gastrin link. Lancet 1989;ii:1167-8.
47. Moss SF, Legon S, Bishop AE, Polak JM, Calam J. Effect of Helicobacter pylon on gastric somatostatin in duodenal ulcer disease. Lancet 1992;340:930-2.
48. Kaneko H, Nakada K, Mitsuma T, Uchida K, Furusawa A, Maeda Y, et al. Helicobacter pylori infection induces a decrease in immunoreactive-somatostatin concentrations of human stomach. Dig Dis Sci 1992;37:409-16.
49. Queiroz DMM, Mendes EN, Rocha GA, Moura SB, Resende LMH, Barbosa AJA, et al. Effect of Helicobacter pylori eradication on antral gastrin- and somatostatin-immunoreactive cell density and gastrin and somatostatin concentrations. Scand J Gastroenterol 1993;28:858-64.
50. Moss SF, Calam J. Acid secretion and sensitivity to gastrin in patients with duodenal ulcer: effect of eradication of Helicobacter pylori. Gut 1993;34:888-92.
51. El-Omar E, Penman ID, Ardill JES, Chittajallu RS, Howie C, McColl KEL. Helicobacter pylori and abnormalities of acid secretion in patients with duodenal ulcer disease. Gastroenterology 1995;109:681-91.
52. Gillen D, El-Omar E, McColl KEL. Parietal sensitivity to gastrin distinguishes H. pylori-infected DU patients from infected healthy volunteers. Gut 1995;37(Suppl 1):A8.
53. McColl KEL, El-Omar E, El-Nujumi A, Wirz A, Covacci A, Crabtree JE. Helicobacter pylori-induced disturbance of gastric acid secretion is unrelated to bacterial CagA status. Gut 1995;36(Suppl 1):A83.
54. Numura A, Stemmermann GN, Chyou P-H, Perez-Perez GI, Blaser MJ. Helicobacter pylori infection and the risk of duodenal and gastric ulceration. Ann Intern Med 1994;120:977-81.
55. Sung JY, Chung SC, Ling TKW, Yung MY, Leung VKS, Ng EKW, et al. Antibacterial treatment of gastric ulcers associated with Helicobacter pylori. N Engl J Med 1995;332:139-42.
56. Labenz J, Borsch G. Evidence for the essential role of Helicobacter pylori in gastric ulcer disease. Gut 1994;35:19-22.
57. McCarthy C, Patchett S, Collins RM, Beattie S, Keane C, O'Morain C. Long-term prospective study of Helicobacter pylori in nonulcer dyspepsia. Dig Dis Sci 1995;40(1):114-9.
58. Parsonnet J, Friedman GD, Vandersteen DP, Chang Y, Vogelman JH, Orentreich N, et al. Helicobacter pylori infection and the risk of gastric carcinoma. N Engl J Med 1991;325:16:1127-31.
59. Forman D, Newell DG, Fullerton F, Yarnell JWG, Stacey AR, Wald N, et al. Association between infection with Helicobacter pylori and risk of gastric cancer: Evidence from a prospective investigation. BMJ 1991;302:1302-5.
60. Hansson LE, Engstrand L, Nyren O, Evans DJ Jr, Lindgren A, Bergstrom R, et al. Helicobacter pylori infection: independent risk indicator of gastric adenocarcinoma. Gastroenterology 1993;105:1098-1103.
61. Correa P, Fox J, Fontham E, Ruiz B, Lin Y, Zavala D, et al. Helicobacter pylori and gastric carcinoma. Serum antibody prevalence in populations with contrasting cancer risks. Cancer 1990;66:2569-73.
62. Correa P, Fox J, Fontham E, Ruiz B, Lin Y, Zavala D, et al. Helicobacter pylori and gastric carcinoma. Serum antibody prevalence in populations with contrasting cancer risks. Cancer 1990;66:2569-73.
63. Eurogast Study Group. An international association between Helicobacter pylori infection and gastric cancer. Lancet 1993;341:1359-62.
64. Sobala GM, Schorah CJ, Lynch DAF, Gallacher B, Dixon MF, Axon ATR. Effect of eradication of Helicobacter pylori on gastric juice ascorbic acid concentrations. Gut 1993;34:1038-41.
65. Banerjee S, Hawksby C, Miller S, Dahill S, Beattie AD, McColl KEL. Effect of Helicobacter pylori and its eradication on gastric juice ascorbic acid. Gut 1994;35:317-22.
66. Sobala GM, Pignatelli B, Schorah CJ, Bartsch H, Sanderson M, Dixon MF, et al. Levels of nitrite, nitrate, N-nitroso compounds, ascorbic acid and total bile acids in gastric juice of patients with and without precancerous conditions of the stomach. Carcinogenesis 1991;12:193-8.
67. Comfort MW, Kelsey MP, Berkson J. Gastric acidity before and after the development of carcinoma of the stomach. J Natl Cancer Inst 1947;7-367-73.
68. El-Omar E, Wirz A, McColl KEL. Divergent effects of H. pylori on acid secretion. Gut 1995;37:A82.
69. Tucci A, Poli L, Paparo GF, Biasco G, Varoli O, Cioffi D, et al. Effect of Helicobacter pylori (HP) eradication in patients with fundic atrophic gastritis. Gut 1994;35(Suppl 4):1514.
70. Yasunaga Y, Shinomura Y, Kanayama S, Yabu M, Nakanishi T, Miyazaki Y, et al. Improved fold width and increased acid secretion after eradication of the organism in Helicobacter pylori associated enlarged fold gastritis. Gut 1994;35:1571-4.
71. Bayerdorffer E, Neubauer A, Rudolph B, Thiede C, Lehn N, Eidt S, et al. Regression of primary gastric lymphoma of mucosa-associated lymphoid tissue type after cure of Helicobacter pylori infection. Lancet 1995;345:1591-4.
72. Hussell T, Isaacson PG, Crabtree JE, Spencer J. The response of cells from low-grade B-cell gastric lymphomas of mucosa-associated lymphoid tissue to Helicobacter pylori. Lancet 1993;342:571-4.
73. NIH Consensus Conference. Helicobacter pylori in peptic ulcer disease. JAMA 1994;272:65-9.
74. Kuipers EJ, Klinkenberg-Knol EC, Havu N, Festen HPM, Lamers CBHW, Jansen JBMJ, et al. Helicobacter pylon and development of atrophic gastritis during omeprazole maintenance therapy. Gastroenterology 1995;108:A137.
75. Tytgat GNJ. Review article: treatments that impact favourably upon the eradication of Helicobacter pylori and ulcer recurrence. Aliment Pharmacol Ther 1994;8:359-68.
76. Penston JG. Review article: Helicobacter pylori eradication - understandable caution but no excuse for inertia. Aliment Pharmacol Ther 1994;8:369-89.
77. Chiba N, Rao BV, Rademaker JW, Hunt R. Meta-analysis of the efficacy of antibiotic therapy in eradicating Helicobacter pylori. Am J Gastroenterol 1992;87:1716-27.
78. Bell GD, Powell KU, Burridge SM, Bowden AF, Atoycbi W, Bolton GU, et al. Rapid eradication of Helicobacter pylori infection. Aliment Pharmacol Ther 1995;9:41-6.
79. Ali-Assi MT, Ramirez FC, Lew GM, Genta RM, Graham DY. Clarithromycin, tetracycline, and bismuth: a new non-metronidazole therapy for Helicobacter pylori infection. Am J Gastroenterol 1994;89:1203-5.
80. Thijs JC, van Zwet AA, Oey HB. Efficacy and side effects of a triple drug regimen for the eradication of Helicobacter pylori. Scand J Gastroenterol 1993;28:934-8.
81. Unge P, Gad A, Gnarpe H, Olsson J. Does omeprazole improve antimicrobial therapy directed towards gastric Campylobacter pylori in patients with antral gastritis? A pilot study. Scand J Gastroenterol 1989;24:49-54.
82. Biasco G, Miglioli M, Barbara L, Corinaldesi R, Di Febo G. Omeprazole, Helicobacter pylori, gastritis and duodenal ulcer. Lancet 1989;ii:1403.
83. Bell GD, Powell KU, Burridge SM, Harrison G, Rameh B, Weil J, et al. Reinfection or recrudescence after apparently successful eradication of Helicobacter pylori infection: implications for treatment of patients with duodenal ulcer disease. Q J Med 1993;86:375-82.
84. Czinn SJ, Nedrud JG. Oral immunization against Helicobacter pylori. Infect Immunol 1991;59:2359-63.